Scholar Rock Competitors and Similar CompaniesClear all
Scholar Rock's competitors and similar companies include Biogen.
 Scholar Rock Scholar Rock is discovering and developing a new class of biologic therapies to selectively target dysregulated growth factors in the disease microenvironment by modulating supracellular activation, resulting in therapeutic effects specifically at the source of disease. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 2012 | Founding Date 1978 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 1401% increase | Employees 7,605 |
Valuation ($) | Valuation ($) 2.8 b | Valuation ($) 26.7 b |
Financial | ||
Net income | Net income ($377.9m) (FY, 2025) | Net income $1.3b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company